Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson’s disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is the most common neurodegenerative motor disorder. The mechanisms underlying the onset and progression of Levodopa (L-Dopa)-induced dyskinesias (LID) during PD treatment remain elusive. Emerging evidence implicates functional modification of microglia in the development of LID. Thus, understanding the link between microglia and the development of LID may provide the knowledge required to preserve or promote beneficial microglial functions, even during a prolonged L-Dopa treatment. To provide novel insights into microglial functional alterations in PD pathophysiology, we characterized their density, morphology, ultrastructure, and degradation activity in the sensorimotor functional territory of the putamen, using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cynomolgus monkeys. A subset of MPTP monkeys was treated orally with Levodopa (L-Dopa) and developed LID similar to PD patients. Using a combination of light, confocal and transmission electron microscopy, our quantitative analyses revealed alterations of microglial density, morphology and phagolysosomal activity following MPTP intoxication that were partially normalized with L-Dopa treatment. In particular, microglial density, cell body and arborization areas were increased in the MPTP monkeys, whereas L-Dopa-treated MPTP animals presented a microglial phenotype similar to the control animals. At the ultrastructural level, microglia did not differ between groups in their markers of cellular stress or aging. Nevertheless, microglia from the MPTP monkeys displayed reduced numbers of endosomes, compared with control animals, that remained lower after L-Dopa treatment. Microglia from MPTP monkeys treated with L-Dopa also had increased numbers of primary lysosomes compared with non-treated MPTP animals, while secondary and tertiary lysosomes remained unchanged. Moreover, a decrease microglial immunoreactivity for CD68, considered a marker of phagocytosis and lysosomal activity, was measured in the MPTP monkeys treated with L-Dopa, compared with non-treated MPTP animals. Taken together, these findings revealed significant changes in microglia during PD pathophysiology that were partially rescued by L-Dopa treatment. Albeit, this L-Dopa treatment conferred phagolysosomal insufficiency on microglia in the dyskinetic Parkinsonian monkeys.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161 · cited 2×
“Using the stereotaxic atlas of Martin and Bowden (Martin and Bowden, 2000), the contour of the sensorimotor functional territory of the putamen was traced at a low magnification on each transverse section, according to Parent and Hazrati (1995).”
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804 · cited 3×
“, 2019), but it is also expressed by peripheral myeloid cells that can infiltrate the brain, especially in contexts of disease, while TMEM119 is considered to be microgliaspecific (Bennett et al., 2016).”
InfluentialMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 1×
“MHC class II and HLA-DR are expressed by microglia and other populations of myeloid cells (McGeer et al., 1988; Perry et al., 2010).”
Microglial interactions with synapses are modulated by visual experience
Tremblay, M.-È., Lowery, R. L., & Majewska, A. K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000527 · Cited by 1,542
Self-citationWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“, 2003), since amoeboid microglia were seen most of the time in the striatum and SN of MPTP mice (Kurkowska-Jastrzebska et al., 1999; Wu et al., 2002).”
Microglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154 · cited 1×
“These morphological changes together define a reactive or “activated” microglial phenotype (Nayak et al., 2014; Tay et al., 2017).”
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096 · cited 1×
“In addition, the morphological index, considered a measure of microglial reactivity to injury or pathological challenges (Streit et al., 1999), was significantly increased in MPTP monkeys compared with the controls (0.”
Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · cited 1×
“PD is thought to result from an interplay between genetic variations and various risk factors such as aging, chronic stress, brain trauma, and infection (Tansey and Goldberg, 2010; Schapira and Jenner, 2011; Vyas et al., 2016; Niraula et al., 2017).”
Microglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919 · cited 1×
“An impaired microglial phagocytosis was previously described in aging and several other contexts of neurodegeneration, supporting the view that microglial dysfunction (in addition to “mild activation”) might contribute to pathology (Streit, 2002; Tremblay et al., 2019).”
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791
Cited by
St-Pierre, M.-K., Carrier, M., Lau, V., & Tremblay, M.-È. (2022) · Methods in Molecular Biology · doi:10.1007/978-1-0716-2409-8_3 · Cited by 29
Self-citationGonzález Ibáñez, F., Halvorson, T., Sharma, K., McKee, C. G., Carrier, M., Picard, K., Vernoux, N., Bisht, K., Deslauriers, J., Lalowski, M., et al. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.09.006 · Cited by 28
Self-citationKhakpour, M., Ibáñez, F. G., Bordeleau, M., Picard, K., Mckee-Reid, L., Ben-Azu, B., Maggi, L., & Tremblay, M.-È. (2022) · Micron · doi:10.1016/j.micron.2022.103334 · Cited by 9
Self-citation
Metadata
- Authors
- Lecours, C., St-Pierre, M.-K., Picard, K., Bordeleau, M., Bourque, M., Awogbindin, I. O., Benadjal, A., Ibanez, F. G., Gagnon, D., Cantin, L., Parent, M., Di Paolo, T., & Tremblay, M.-E.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 90
- Pages
- 81-96
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W3046416599
- Cited by
- 36
- References
- 30
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.